mesalamine and Substance Withdrawal Syndrome
mesalamine has been researched along with Substance Withdrawal Syndrome in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
" Treatment-related adverse events were rare." | 2.68 | Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group. ( Arora, S; Hanauer, S; Miner, P; Robinson, M; Schwartz, J, 1995) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Miner, P | 1 |
Hanauer, S | 1 |
Robinson, M | 1 |
Schwartz, J | 1 |
Arora, S | 1 |
Trials
1 trial available for mesalamine and Substance Withdrawal Syndrome
Article | Year |
---|---|
Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Capsules; Colitis, Ulcerative; | 1995 |